Connect with us
Novartis plans to sell Morphosys' business, acquired for €2.7 billion in 2023, affecting 330 employees as it closes two factories by 2025. Initially aimed at boosting...
Novo Nordisk completed the €10.66 billion acquisition of Catalent, including three production plants to scale up Wegovy production. Despite rivals' opposition, the deal secures Novo’s market...
Roche's CE Mark-approved cobas Mass Spec offers automated, standardized mass spectrometry for over 60 tests, improving care for breast cancer and hormonal therapy patients. It aids...
Ozempic, manufactured by Novo Nordisk, gains EMA approval for chronic kidney disease, reducing disease progression by 24%, per the Flow trial. With 40% of type 2...
Bayer expands its Barcelona innovation hub with a new R&D area for health and agriculture, integrating 82 professionals to advance clinical trials and medicine safety. The...
Quirónsalud and Roche Farma España have signed a partnership to advance healthcare innovation and clinical research, focusing on oncology, neurosciences, and ophthalmology. The agreement includes precision...
Croma Gio.Batta Iberia, post-merger with Cogesa, anticipates double-digit growth fueled by a 15% revenue rise to over €30M. The group, now a leading provider of healthcare...
Eli Lilly will invest $3 billion to expand its Kenosha, Wisconsin, facility, acquired for $100 million in April. The site will manufacture injectable diabetes and obesity...
Sanofi will invest €1 billion in a new insulin factory in Beijing, its largest investment in China, citing demand from 140 million diabetic adults. This fourth...
Mason Capital, owning 2.1% of Grifols' Class A shares, seeks Tomás Dagá's resignation, citing governance concerns and shareholder value loss. The fund demands transparency on Dagá’s...